Dr. Iván R. González (@dr_ivanoncologo) 's Twitter Profile
Dr. Iván R. González

@dr_ivanoncologo

Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.

ID: 515209390

linkhttps://linktr.ee/drivanromaricogonzalezespinoza calendar_today05-03-2012 07:37:51

9,9K Tweet

4,4K Followers

4,4K Following

Dr. Iván R. González (@dr_ivanoncologo) 's Twitter Profile Photo

🚨 The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection in adults for all indications of its intravenous formulation, including NSCLC, SCLC, HCC, melanoma, and ASPS. 📉In the IMscin001 trial, the confirmed

🚨 The FDA approved atezolizumab and hyaluronidase-tqjs  for subcutaneous injection in adults for all indications of its intravenous formulation, including NSCLC, SCLC, HCC, melanoma, and ASPS.                                             
📉In the IMscin001 trial, the confirmed